Is the Eclipx Group share price in the buy zone yet?

The Eclipx Group Ltd (ASX: ECX) share price fell 56% after a negative ASX update before rebounding to $1.24 per share at market close – is it in the buy zone?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Eclipx Group Ltd (ASX: ECX) share price fell 56% in one day to $0.57 per share after a negative ASX update before rebounding to $1.24 per share at market close – but is it in the buy zone?

What happened to Eclipx to start the year?

In mid-March this year, Eclipx emerged from its trading halt with an update announcing a 42.4% decrease in net profit after tax and adjustments (NPATA), compared to the first five months of FY18.

The company also announced that its financial performance had "softened" since its 29 January 2019 update as its Grays Industrial and Insolvency segments continued to underperform, and that it was looking at divesting non-core assets.

Both Eclipx management and McMillan Shakespeare Limited (ASX: MMS) announced that a planned merger was "unlikely" as McMillan pointed to several key issues in Eclipx's trading update, including the NPATA decline and ongoing underperformance.

Could the Eclipx share price be in the buy zone?

I'm not personally in the game of distressed investing, but so far Eclipx looks like it might be back in the buy zone.

If you had managed to buy in the dip immediately following the crash, you would have netted yourself a tidy 117% profit in just a few months, which is greater than the share price performance of Afterpay Touch Group Ltd (ASX: APT) or Appen Ltd (ASX: APX) over the last 6 months.

Eclipx management has made a few structural changes and look to be plotting a path back to profitability, after non-cash impairment of assets and a change of senior leadership (including the CFO) in the subsequent months.

Eclipx's first-half earnings (released at the end of May) were indicative of the difficult 6 months the company has endured, but if market conditions hold and the company can stick to its strategy, I think the full-year accounts could show improved performance and a share price rebound for brave investors.

Motley Fool contributor Lachlan Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »